Brief: Beam Therapeutics Inc - Plans To Submit A Regulatory Application For Authorization To Initiate Clinical Trials Of Beam-302 In Q1 Of 2024
07/09/2023 16:50
Sept 7 (Reuters) - Beam Therapeutics Inc BEAM.O :
* BEAM THERAPEUTICS INC - PLANS TO SUBMIT A REGULATORY
APPLICATION
FOR AUTHORIZATION TO INITIATE CLINICAL TRIALS OF BEAM-302 IN Q1
OF 2024
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Beam Therapeutics
See all newsBeam Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Beam Therapeutics Q1 net loss narrows beating analyst estimates
U.S. STOCKS ON THE MOVE-ADMA Biologics, Nanobiotix, DraftKings
U.S. STOCKS ON THE MOVE-BWX, Generac, Cintas
U.S. STOCKS ON THE MOVE-Arm, On Holding, Sarepta